Literature DB >> 14522544

COMET: a proposed mechanism of action to explain the results and concerns about dose.

Ake Hjalmarson, Finn Waagstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522544     DOI: 10.1016/S0140-6736(03)14422-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].

Authors:  G Ertl; S Nitschmann
Journal:  Internist (Berl)       Date:  2004-07       Impact factor: 0.743

2.  Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).

Authors:  Christian Torp-Pedersen; Marco Metra; Andrew Charlesworth; Phillip Spark; Mary Ann Lukas; Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Willem J Remme; Armin Scherhag
Journal:  Heart       Date:  2007-01-19       Impact factor: 5.994

Review 3.  Beta blockers as anti-arrhythmic agents.

Authors:  Daejoon Anh; Joseph E Marine
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

Review 4.  Beta-blockers in heart failure: are pharmacological differences clinically important?

Authors:  Marco Metra; Livio Dei Cas; Andrea di Lenarda; Philip Poole-Wilson
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

Review 5.  Drug treatment of chronic heart failure in the elderly.

Authors:  Gregor Leibundgut; Matthias Pfisterer; Hans-Peter Brunner-La Rocca
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

6.  Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.

Authors:  Hans-Dirk Düngen; Svetlana Apostolovic; Simone Inkrot; Elvis Tahirovic; Agnieszka Töpper; Felix Mehrhof; Christiane Prettin; Biljana Putnikovic; Aleksandar N Neskovic; Mirjana Krotin; Dejan Sakac; Mitja Lainscak; Frank Edelmann; Rolf Wachter; Thomas Rau; Thomas Eschenhagen; Wolfram Doehner; Stefan D Anker; Finn Waagstein; Christoph Herrmann-Lingen; Goetz Gelbrich; Rainer Dietz
Journal:  Eur J Heart Fail       Date:  2011-03-23       Impact factor: 15.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.